Cofoe Medical Technology's major shareholder plans to repurchase 1-2 billion A-shares.

Cofoe Medical Technology (01187) announced that, based on confidence in the company's future development and recognition of the company's value, in order to effectively protect the interests of all shareholders and enhance investor confidence, considering factors such as business performance, financial condition, future profitability, and reasonable valuation levels, the company plans to repurchase a portion of its Class A shares through centralized bidding trading. The repurchased shares will be cancelled and the company's registered capital will be reduced. The repurchase price for this time shall not exceed RMB 69.66 per share (inclusive), and the total amount of funds intended for repurchase shall not be less than RMB 100 million (inclusive), nor exceed RMB 200 million (inclusive). The source of funds for this repurchase of Class A shares shall be the company's own funds and special loan funds for stock repurchase. CITIC BANK Co., Ltd. Changsha Branch has committed to provide the company with special loan support not exceeding RMB 180 million. The specific loan matters shall be subject to the loan contract signed between the two parties.